← Back to Intel
Insider ActivityXERS
Brady James Aloysius, Director at Xeris Biopharma Holdings, Inc., sold $60K of XERS
Updated Jun 13, 2026
Brady James Aloysius
Director
Xeris Biopharma Holdings, Inc. ·
$XERS
Transaction Details
| Insider | Brady James Aloysius |
|---|---|
| Title | Director |
| Company | Xeris Biopharma Holdings, Inc. |
| Ticker | XERS |
| Transaction Type | Sale |
| Transaction Date | 2026-03-30 |
| Shares Traded | 10,834 |
| Price Per Share | $5.5414 |
| Total Value | $60K |
| Filed Date | 2026-04-01 |
| Accession Number | 0001916987-26-000002 |
Ownership Context
| Shares Owned After Transaction | 89,166 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001916987-26-000002
Other Insider Trades — XERS
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | traded | $203K | 2026-06-04 |
| HALKUFF DAWN | Director | traded | — | 2026-06-04 |
| HALKUFF DAWN | Director | traded | $203K | 2026-06-04 |
| BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | sold | $98K | 2026-06-04 |
| BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | traded | — | 2026-06-04 |
| Brady James Aloysius | Director | traded | — | 2026-06-04 |
| Brady James Aloysius | Director | traded | $203K | 2026-06-04 |
| PERSKY MARLA | Director | traded | — | 2026-06-04 |
| PERSKY MARLA | Director | traded | $203K | 2026-06-04 |
| JOHNSON JOHN | Director | sold | $91K | 2026-06-04 |
Other Trades by Brady James Aloysius
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | traded | — | 2026-06-04 |
| XERS | Xeris Biopharma Holdings, Inc. | traded | $203K | 2026-06-04 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for XERS — Xeris Biopharma Holdings, Inc. →
Whisper Score — XERS
53.8
Active Discussion
Current Whisper Score
Track XERS insider activity in real time on The Wire →
Get alerts when Brady James Aloysius files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 13, 2026 at 07:20 UTC